ABSTRACT
INTRODUCTION
Coronary heart desease (CHD) remains the leading cause of death in the industrialized countries. The primary cause of CHD is athemsclemsis, a disease characterized by the deposition of lipids in the artedal vessel wall, resulting in a narrowing of the vessel passages and ultimately hardening the vascular system.
Atherosclerosis as manifested in its major clinical complication, ischaemic heart disease, is thought to begin with local injury to the arterial endothelium followed by proliferation of artedal smooth muscle cells from the medial layer to the intJmal layer along with deposition of lipid and accumulation of foam cells in the lesion. As the athemsclerotic plaque develops, it progressively occludes more and more blood vessel and can eventually lead to ischaemia or infarction. Therefore, it is desirable to provide a method of inhibiting the progression of atherosclemsis in patients.
Elevated cholesterol levels are also associated with a number of disease states. Therefore it is desirable to provide a method for reducing plasma cholesterol in patients with, or at risk of developing restenosis, angina, cerebral arteriosclerosis, and xanthoma.
Hetemcyclic sulfides exhibit a wide spectrum of activity on heart and blood cimulatory system. For example, pyridine sulfides display cholesterol acyltransferase inhibitor [1] , blood sugar reduction [2] , vasodilating [3] [4] [5] [6] [7] , vasopressing [8] , antihypertensive [4, 5, 7, 9, 10] , hypotensive [6] , hypoglycemic [11] [12] [13] , anticholesteremic [14] , euglicemic and hypolipidemic [15] , cardiotonic [16] , cardiovascular and cardioprotective [17] activities. Quinoline sulfides exhibit vasodilating [18] [19] [20] [21] [22] [23] [24] , antihypertensive [18, 19] , hypotensive [23, 30] , euglicemic and hypolipidemic [15] , antithrombotic [31, 32] and cardiotonic [32] activities. Thiazole and benzothiazole sulfides display vasodilating [33] [34] [35] , and hypotensive [35] activities and may be used as hypolipemics and in treatment of arteriosclerosis [36] . Imidazole sulfides increase high density lipoprotein cholesterol over lipid fractions [37] and were used in the treatment of athemsclerosis [38] . Hypoglycemic activity of N-{4- [39] and vasodilating activity of 6-quinazolinesulfonyl derivatives [40] are evaluated too.
The silicon and germanium containing heteroammatic sulfides as cholesterol level lowering and vasodilating agents have not been studied. In this view the silyl and germyl S-substituted derivatives of N-and S-heterocyclic thiols are of interest as substances with the possible above described activity.
The preparation of the compounds possessing serum cholesterol level lowering property [41] is the aim of our work.
The known methods for the preparation of hetan/I sulfides are based on the reaction of hetaryl thiols with alkyl or aryl halides in the K2CO3 / Me2CO [42] , NaOMe / DMF [43] or Nail / Me2SO, [44] systems. Recently we described two simple phase transfer catalytic (PTC) methods for the preparation of hetaryl sulfides in the hetaryl thiol / alkyl halide / solid K2CO3 / 18-crown-6 / toluene [45] or hetaryl S-acetate / aikyl halide / solid KOH / 18-crown-6 / benzene systems [46] .
We have used the first [45] 9 Weeks after start of the experiment the total and HDH cholesterol were determined in the serum of intact control and high-cholesterol diet animals (3 from each group). High-cholesterol diet group was divided into Cholesterol control group (7 mice) and 5 groups (6 mice each) treated with the studied compounds (10 rng/kg i.p. once a day for 3 weeks).
At the end of the experiment (12 weeks), the mice after overnight fasting were killed by withdrawing blood from the abdominal aorta under ether anaestesia. Serum was separated by centrifugation (1500 g for min), and high-density lipoprotein (HDL) fraction was immediately separated from a portion of the serum by the heparin-manganese precipitation procedure.
Total and HDL cholesterol in the serum and aorta were determined flumenzymatically.
The results obtained were expressed as the mean + SEM of data from 5-7 mice per group.
VASODILA TING ACTIVITYASSA Y
The modified classical method for the experiments on the isolated perfused rabbit ear blood vessels was used. Rabbits of both sexes (2.6-3.3 kg) were killed by i.v. injection of pentobarbital sodium (80 rng/kg). The central ear artery was dissected free at the base of the ear and cannulated with polyethylene tubing and perfused at a constant flow (2ml/min) from 4-channel peristaltic pump Gemini (Italy).
The content of the perfusion fluid (mmol) was as follows: NaCI 136.9; KCI 2.68; CaCI2 1.8; MgCI2 1.05; NaHCO3 11.9; NaH2PO4 0.42; glucose 5.6 
ACUTE TOXICITYASSAY
The acute toxicity was evaluated in male ICR-JCL mice (19-23 g ). The compounds were dissolved-suspended in 0.6% solution of Twin 80 and injected i.p. To reduce the number of the used animals and the amount of compounds the maximal dose (400-600 mg/kg, i.p.) was used. If possible LDs0 was calculated when 50% of the animals died. 3 (a-e)-9 (a-e)
The purity of the synthesized compounds was detected with HPLC (<1.5% of impurities). All substances were mobile oils therefore the elemental analysis was performed only for 8a and 9a.
The structures and spectral characteristics of synthesized substances are shown in Tables 3   and 4 . The Table 5 The cholesterol level lowering activity depends also on the substituent position in the ring: the 2-position in the pyddine and quinoline is more preferable. Thus 2-[(y-tdmethylsilylpropyl)thio] derivatives of pyridine 4a and quinoline 6a are more active than the similar derivatives of 4-pyddine 5a and 8-quinoline 7a. (15) '.. The studied compounds have a medium toxicity. The most toxic was silyl substituted imidazole sulfide 3b (200 mg/kg). The replacement of silicon atom by germanium one (3e) leads to the decrease of acute toxicity (435 mg/kg). In general, silyl and germyl substituted benzothiazoles (Sb e) are less toxic than the corresponding imidazole analogues (3b, lh).
CONCLUSIONS
The PTC method of the synthesis of hetemcyclic silyl-and germylalkylsulfides was elaborated. Thirteen compounds were synthesized and isolated in the yield up to 92%. They were studied as serum cholesterol level lowering agents. It has been found that silicon and germanium containing heteroaromatic sulfides possess the cholesterol level lowering activity. The 1-methylimidazole, benzothiazole and 2-quinoline derivatives 3e, 6a, 8a, b, e exhibit the highest level of activity. The substances containing dimethyl(l-triethylgermylethyl)silylmethyl-(3e) and dimethyl(l-triphenylsilylethyl)silylmethyl-(8d) substituents were the most active.
Ten of the elaborated compounds were tested on the vasodilating activity. It was shown that 1-methylimidazole derivatives 3a, 3e possess the vasodilating activity. The compounds containing benzothiazole have the different influence. Compound with dimethyl(l-triethylsilylethyl)silylmethyl-substituent (8c) has the relaxation effect. On contrary the 3-trimethylsilylpropyl-(8a) and dimethyl(l-triphenylsilylethyl)silylmethyl (8d) benzothiazole derivatives possess the contraction effect.
The toxicity of the studied substances was low. It was shown that germanium derivative 3e
was less toxic than its silicon analogue 3b. The introduction of the second silicon or germanium atom also decreases acute toxicity of the compound (Sa and 8b, c, d, e).
